Vosol label

Vosol

Vosol Recall

Get an alert when a recall is issued.

Side Effects & Adverse Reactions

Discontinue promptly if sensitization or irritation occurs.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

For the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial.

History

There is currently no drug history available for this drug.

Other Information

VōSoL (Acetic acid otic solution, USP) is a solution containing acetic acid (2%) in a propylene glycol vehicle containing propylene glycol diacetate (3%), benzethonium chloride (0.02%), and sodium acetate (0.015%). The empirical formula for acetic acid is CH3COOH, with a molecular weight of 60.05. The structural formula is:

Acetic Acid Structural Formula

VōSoL is available as a nonaqueous otic solution buffered at pH 3 for use in the external ear canal.

Vosol Manufacturers

  • Vosol | Ecr Pharmaceuticals Co., Inc.
    No Recall

    Vosol | Ecr Pharmaceuticals Co., Inc.

    Vosol | Ecr Pharmaceuticals Co., Inc.

    Carefully remove all cerumen and debris to allow VōSoL to contact infected surfaces directly. To promote continuous contact, insert a wick of cotton saturated with VōSoL into the ear canal; the wick may also be saturated after insertion. Instruct the patient to keep the wick in for at least 24 hours and to keep it moist by adding 3 to 5 drops of VōSoL every 4 to 6 hours. The wick may be removed after 24 hours but the patient should continue to instill 5 drops of VōSoL 3 or 4 times daily thereafter, for as long as indicated. In pediatric patients, 3 to 4 drops may be sufficient due to the smaller capacity of the ear canal.